Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing long-term observation of Gliadel wafer in high-grade glioma
jRCT1080222548
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of carmustine in malignant glioma and glioma, sponsored by Eisai Co., Ltd. Primary endpoint: Vital prognosis / overall survival.
02
Drugs
carmustine
03
Conditions
malignant gliomaglioma
Beyond the preview
Go deeper on jRCT1080222548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222548.